Cargando…

The Evaluation of Rac1 Signaling as a Potential Therapeutic Target of Alzheimer’s Disease

The Small GTPase Rac1 is critical for various fundamental cellular processes, including cognitive functions. The cyclical activation and inactivation of Rac1, mediated by Rac guanine nucleotide exchange factors (RacGEFs) and Rac GTPase-activating proteins (RacGAPs), respectively, are essential for a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Huanhuan, Yamahashi, Yukie, Riedl, Marcel, Amano, Mutsuki, Kaibuchi, Kozo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418761/ https://www.ncbi.nlm.nih.gov/pubmed/37569255 http://dx.doi.org/10.3390/ijms241511880

Ejemplares similares

Phosphorylation Signals Downstream of Dopamine Receptors in Emotional Behaviors: Association with Preference and Avoidance
por: Zhang, Xinjian, et al.
Publicado: (2022)

KANPHOS: A Database of Kinase-Associated Neural Protein Phosphorylation in the Brain
por: Ahammad, Rijwan Uddin, et al.
Publicado: (2021)

Rho-Kinase/ROCK: A Key Regulator of the Cytoskeleton and Cell Polarity
por: Amano, Mutsuki, et al.
Publicado: (2010)

Phosphoproteomic of the acetylcholine pathway enables discovery of the PKC-β-PIX-Rac1-PAK cascade as a stimulatory signal for aversive learning
por: Yamahashi, Yukie, et al.
Publicado: (2022)

Identification of the Kinase-Substrate Recognition Interface between MYPT1 and Rho-Kinase
por: Amano, Mutsuki, et al.
Publicado: (2022)

Rho-Kinase–Mediated Contraction of Isolated Stress Fibers
por: Katoh, Kazuo, et al.
Publicado: (2001)

Rac1 in human diseases: The therapeutic potential of targeting Rac1 signaling regulatory mechanisms
por: Marei, Hadir, et al.
Publicado: (2016)

Rho-Kinase Phosphorylates COOH-terminal Threonines of Ezrin/Radixin/Moesin (ERM) Proteins and Regulates Their Head-to-Tail Association
por: Matsui, Takeshi, et al.
Publicado: (1998)

Rho-Kinase/ROCK Phosphorylates PSD-93 Downstream of NMDARs to Orchestrate Synaptic Plasticity
por: Hossen, Emran, et al.
Publicado: (2022)

Roles of Rho-associated Kinase in Cytokinesis; Mutations in Rho-associated Kinase Phosphorylation Sites Impair Cytokinetic Segregation of Glial Filaments
por: Yasui, Yoshihiro, et al.
Publicado: (1998)

Phosphorylation of Myosin-Binding Subunit (Mbs) of Myosin Phosphatase by Rho-Kinase in Vivo
por: Kawano, Yoji, et al.
Publicado: (1999)

Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology
por: Fujita, Kyota, et al.
Publicado: (2018)

Discovery of long-range inhibitory signaling to ensure single axon formation
por: Takano, Tetsuya, et al.
Publicado: (2017)

A Proteomic Approach for Comprehensively Screening Substrates of Protein Kinases Such as Rho-Kinase
por: Amano, Mutsuki, et al.
Publicado: (2010)

Kinase-interacting substrate screening is a novel method to identify kinase substrates
por: Amano, Mutsuki, et al.
Publicado: (2015)

Neuronal Polarity: Positive and Negative Feedback Signals
por: Takano, Tetsuya, et al.
Publicado: (2019)

The Ratio of RAC1B to RAC1 Expression in Breast Cancer Cell Lines as a Determinant of Epithelial/Mesenchymal Differentiation and Migratory Potential
por: Eiden, Caroline, et al.
Publicado: (2021)

Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease
por: Khan, Fabiha Zaheen, et al.
Publicado: (2022)

The inositol 5-phosphatase SHIP2 is an effector of RhoA and is involved in cell polarity and migration
por: Kato, Katsuhiro, et al.
Publicado: (2012)

Inhibition of the Action of a Stimulatory GDP/GTP Exchange Protein for smg p21 hy Acidic Membrane Phospholipids
por: Kawamura, Shiro, et al.
Publicado: (1991)

The Role of Wnt Signaling in the Development of Alzheimer's Disease: A Potential Therapeutic Target?
por: Wan, Wenbin, et al.
Publicado: (2014)

Rac1, A Potential Target for Tumor Therapy
por: Liang, Jiaxin, et al.
Publicado: (2021)

Novel Selective Butyrylcholinesterase Inhibitors Incorporating Antioxidant Functionalities as Potential Bimodal Therapeutics for Alzheimer’s Disease
por: Jones, Mike, et al.
Publicado: (2016)

Interplay of PKA and Rac: Fine-tuning of Rac localization and signaling
por: Bachmann, Verena A, et al.
Publicado: (2013)

Rac-GEF/Rac Signaling and Metastatic Dissemination in Lung Cancer
por: Cooke, Mariana, et al.
Publicado: (2020)

Tiam1 interaction with the PAR complex promotes talin-mediated Rac1 activation during polarized cell migration
por: Wang, Shujie, et al.
Publicado: (2012)

Rac1 is a novel therapeutic target in mantle cell lymphoma
por: Tian, Tian, et al.
Publicado: (2018)

Ferroptosis, a Potential Therapeutic Target in Alzheimer’s Disease
por: Chen, Kai, et al.
Publicado: (2021)

Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s Disease
por: Liu, Ping, et al.
Publicado: (2022)

Neutrophils as a potential therapeutic target in Alzheimer’s disease
por: Aries, Michelle L., et al.
Publicado: (2023)

Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment
por: Atlante, Anna, et al.
Publicado: (2022)

Tau-tubulin kinase 1 and amyloid-β peptide induce phosphorylation of collapsin response mediator protein-2 and enhance neurite degeneration in Alzheimer disease mouse models
por: Ikezu, Seiko, et al.
Publicado: (2020)

Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC)
por: Skvortsov, S, et al.
Publicado: (2014)

Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer’s Disease and Parkinson’s Disease
por: Tapias, Victor, et al.
Publicado: (2023)

Rac1 as a multifunctional therapeutic target to prevent and combat cancer metastasis
por: Arnold, Christoph R., et al.
Publicado: (2014)

RAC1 Activation as a Potential Therapeutic Option in Metastatic Cutaneous Melanoma
por: Colón-Bolea, Paula, et al.
Publicado: (2021)

The Rac inhibitor HV-107 as a potential therapeutic for metastatic breast cancer
por: Crespo, Grace Velez, et al.
Publicado: (2023)

EphB2: potential therapeutic target for Alzheimer’s disease
Publicado: (2011)

The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
por: Pritchard, Susanne M, et al.
Publicado: (2011)

Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
por: Nizami, Sohaib, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ul9p80eshj8e23dubfnkn6sk74